GlassScriptPhysician profile
Jose Suros
NPI 1609998434
$2,357.64
in general payments reported to CMS, 2019-2025
22 companies · $394 in 2025
The $394 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $191 · 2021: $340 · 2022: $189 · 2023: $434 · 2024: $311 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,138.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $574.25 | 2022-2025 | Botox |
| Allergan, INC. | $382.69 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $203.01 | 2021-2024 | Xtampza, Belbuca |
| Lundbeck LLC | $200.38 | 2024-2025 | Vyepti |
| Amgen INC. | $185.14 | 2019 | |
| Boston Scientific Corporation | $138.67 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Axogen | $94.92 | 2023 | Avance Nerve Graft |
| Averitas Pharma INC. | $87.14 | 2024-2025 | Qutenza |
| Bioventus LLC | $76.31 | 2019-2025 | Xcell |
| Lilly USA, LLC | $74.86 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $66.94 | 2023 | Spravato |
| Abbott Laboratories | $46.72 | 2021-2025 | Eterna |
| Teva Pharmaceuticals USA, INC. | $35.04 | 2020 | |
| Smith+Nephew, INC. | $34.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.32 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $29.46 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $24.23 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $18.63 | 2019 | |
| Medtronic USA, INC. | $15.61 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.46 | 2024 | Relistor |
| Almatica Pharma LLC | $12.29 | 2021 | |
| Shionogi INC | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Suros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.